There are some proposed changes to the Medicare Shared Savings Program (MSSP) that may be favorably or not depending on the accountable care organization (ACO) and its situation, said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
There are some proposed changes to the Medicare Shared Savings Program (MSSP) that may be favorably or not depending on the accountable care organization (ACO) and its situation, said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
Transcript
What are some proposed changes to the MSSP that some ACOs might see as an opportunity, but others might view as a challenge?
There’s a lot of complexity in this program, and as we look at the impact of certain proposals on various ACOs it can affect ACOs differently. So, a good example of this is benchmarking, where we see a proposal that would change how CMS incorporates a component of regional expenditure data into the benchmark. And the goal of that policy is to avoid comparing ACOs only to their historical performance as times moves on.
And this is something that we’re very supportive of—moving away from just looking at those historical expenditures. If we remain just looking at historical expenditures, eventually they’ll get so low that people can’t achieve savings and always beat their past performance. So, a way to fix that problem is to increasingly compare ACOs to other providers in their region. Some of the proposals in the benchmark change how CMS would incorporate that regional comparison into the benchmark. So, certain ACOs may view that favorably and other ACOs may not view it favorably, depending on how they compare to their regional costs.
Another example is risk adjustment. We are definitely pleased to see some of the proposals CMS put forward with risk adjustment. But some of the other elements of the proposal will be harmful to certain ACOs, so, we’re making some recommendations for CMS to finalize some of elements of the risk adjustment proposals and then modify other elements.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More